secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001104659-23-125598
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents closes $10.3M registered direct offering with insider participation
--------------------------------------------------------------------------------

- Closed offering of 7,733,090 shares and warrants for 2,706,561 shares at $1.33/unit, gross $10.3M.
- Net proceeds ~$9.83M; warrants exercisable at $2.00/share, expire in 5 years.
- Insiders (C-suite, board, key leaders) invested $435,000 in the offering.
- Proceeds to fund DrugSorb-ATR regulatory efforts, CytoSorb growth, clinical studies, and R&D.
- CEO expects initial STAR-T trial data before end of December 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923125598/0001104659-23-125598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923125598/tm2332718d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-125598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer